Alzheimer’s Disease Severity is Not Significantly Associated with Short Sleep: Survey by Actigraphy on 208 Mild and Moderate Alzheimer’s Disease Patients
Restricted accessResearch articleFirst published online November 1, 2016
Alzheimer’s Disease Severity is Not Significantly Associated with Short Sleep: Survey by Actigraphy on 208 Mild and Moderate Alzheimer’s Disease Patients
Background: In epidemiological surveys, cognitive decline has been found to be associated with both short and long sleep duration.
Objective: Our goal was to objectively determine how total sleep time (TST) at night was associated or not with apathy or severity scores in patients with Alzheimer ’s disease (AD).
Methods: During an observational first step of a clinical trial, sleep was assessed in institutionalized patients with mild or moderate AD using actigraphy (MW8, Camtech, Cambridge, UK) for 14 consecutive 24-hour periods. Sleep parameters analyzed were: TST, time in bed (TIB), wake after sleep onset (WASO), sleep efficiency (SE) defined by the ratio TST/TIB, in percentage), the number and length of awakenings, the night fragmentation index, the interdaily stability, and intradaily variability indexes. Statistical association analyses were tested between these values and AD apathy and severity scores.
Results: 208 individuals coming from 82 centers worldwide (France, Germany, Spain, Italy, Portugal, Poland, United States, Canada, and Australia) and≥50 years old participated. Their average TST was 7 hours and 35 minutes and the average WASO 58 minutes. TST and SE were significantly higher in patients with apathy and the number of awakenings was significantly lower. TST was also positively associated with functional disability (ADCS-ADL scores), but it was not found significantly greater in patients with a moderate AD severity compared to the mild.
Conclusion: Despite several and long awakenings, TST was not shorter in patients with AD. TST was even significantly increased with disability and apathy.
MonsellSE, MockC, RoeCM, GhoshalN, MorrisJC, CairnsNJ, KukullW (2013) Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology. Neurology80, 2121–2129.
10.
HatfieldCF (2004) Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer’s dementia. Brain127, 1061–1074.
11.
WilsonRS, HogansonGM, RajanKB, BarnesLL, Mendes de LeonCF, EvansDA (2010) Temporal course of depressive symptoms during the development of Alzheimer disease. Neurology75, 21–26.
12.
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders (DSM-5)®, American Psychiatric Association, Washington, DC.
13.
McCurrySM, PikeKC, VitielloMV, LogsdonRG, TeriL (2008) Factors associated with concordance and variability of sleep quality in persons with Alzheimer’s disease and their caregivers. Sleep31, 741–748.
14.
FriedmanLF, ZeitzerJM, LinL, HoffD, MignotE, PeskindER, YesavageJA (2007) In Alzheimer disease, increased wake fragmentation found in those with lower hypocretin-1. Neurology68, 793–794.
15.
ICSD-3 (2014) The International Classification of Sleep Disorders, American Academy of Sleep Medicine, Darien, IL.
16.
CappuccioFP, D’EliaL, StrazzulloP, MillerMA (2010) Quantity and quality of sleep and incidence of type 2 diabetes: A systematic review and meta-analysis. Diabetes Care33, 414–420.
17.
FarautB, TouchetteE, GambleH, Royant-ParolaS, SafarME, VarsatB, LégerD (2012) Short sleep duration and increased risk of hypertension: A primary care medicine investigation. J Hypertens30, 1354–1363.
18.
Theorell-HaglöwJ, BerglundL, JansonC, LindbergE (2012) Sleep duration and central obesity in women - differences between short sleepers and long sleepers. Sleep Med13, 1079–1085.
19.
BuxtonOM, MarcelliE (2010) Short and long sleep are positively associated with obesity, diabetes, hypertension, and cardiovascular disease among adults in the United States. Soc Sci Med71, 1027–1036.
20.
De Toledo Ferraz AlvesTC, FerreiraLK, WajngartenM, BusattoGF (2010) Cardiac disorders as risk factors for Alzheimer’s disease. J Alzheimers Dis20, 749–763.
21.
HerbertJ, LucassenPJ (2016) Depression as a risk factor for Alzheimer’s disease: Genes, steroids, cytokines and neurogenesis - What do we need to know?Neuroendocrinol41, 153–171.
CamargosEF, LouzadaFM, NóbregaOT (2013) Wrist actigraphy for measuring sleep in intervention studies with Alzheimer’s disease patients: Application, usefulness, and challenges. Sleep Med Rev17, 475–488.
24.
DuboisB, FeldmanHH, JacovaC, DekoskyST, Barberger-GateauP, CummingsJ, DelacourteA, GalaskoD, GauthierS, JichaG, MeguroK, O’brienJ, PasquierF, RobertP, RossorM, SallowayS, SternY, VisserPJ, ScheltensP (2007) Research criteria for the diagnosis of Alzheimer’s disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol6, 734–746.
25.
FolsteinMF, FolsteinSE, McHughPR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res12, 189–198.
26.
HachinskiVC, IliffLD, ZilhkaE, Du BoulayGH, McAllisterVL, MarshallJ, RussellRW, SymonL (1975) Cerebral blood flow in dementia. Arch Neurol32, 632–637.
27.
MölsäPK, PaljärviL, RinneJO, RinneUK, SäköE (1985) Validity of clinical diagnosis in dementia: A prospective clinicopathological study. J Neurol Neurosurg Psychiatry48, 1085–1090.
28.
NetzerNC, StoohsRA, NetzerCM, ClarkK, StrohlKP (1999) Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med131, 485–491.
29.
GalaskoD, BennettD, SanoM, ErnestoC, ThomasR, GrundmanM, FerrisS (1997) An inventory to assess activities of daily living for clinical trials in Alzheimer’s disease. The Alzheimer’s Disease Cooperative Study. Alzheimer Dis Assoc Disord11(Suppl 2), .S33–S39.
30.
CummingsJL, MegaM, GrayK, Rosenberg-ThompsonS, CarusiDA, GornbeinJ (1994) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology44, 2308–2314.
31.
MarinRS, BiedrzyckiRC, FirinciogullariS (1991) Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res38, 143–162.
32.
LittnerM, KushidaCA, AndersonWM, BaileyD, BerryRB, DavilaDG, HirshkowitzM, KapenS, KramerM, LoubeD, WiseM, JohnsonSF, Standardsof Practice Committee of the American Academy of Sleep Medicine (2003) Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: An update for 2002. Sleep26, 337–341.
33.
OakleyNR (1997) Validation with polysomnography of the Sleepwatch sleep/wake scoring algorithm used by the Actiwatch activity monitoring system. Technical Report to Mini Mitter Co., Inc., Bend, Oregon.
OhayonMM, CarskadonMA, GuilleminaultC, VitielloMV (2004) Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: Developing normative sleep values across the human lifespan. Sleep27, 1255–1273.
36.
OhayonMM, VecchieriniM-F (2005) Normative sleep data, cognitive function and daily living activities in older adults in the community. Sleep28, 981–989.
37.
LégerD, RoscoatE, du BayonV, GuignardR, PâquereauJ, BeckF (2011) Short sleep in young adults: Insomnia or sleep debt? Prevalence and clinical description of short sleep in a representative sample of 1004 young adults from France. Sleep Med12, 454–462.
38.
LégerD,
BeckF,
RichardJB,
SauvetF,
FarautB (2014). The risks of sleeping “too much” Survey of a national representative sample of 24671 adults (INPES Health Barometer). PLoS One16, e106950.
39.
Van SomerenEJW (2007) Improving actigraphic sleep estimates in insomnia and dementia: How many nights?J Sleep Res16, 269–275.
40.
RamosAR, DongC, ElkindMSV, Boden-AlbalaB, SaccoRL, RundekT, WrightCB (2013) Association between sleep duration and the mini-mental score: The Northern Manhattan study. J Clin Sleep Med9, 669–673.
41.
JooEY, YoonCW, KooDL, KimD, HongSB (2012) Adverse effects of 24 hours of sleep deprivation on cognition and stress hormones. J Clin Neurol8, 146–150.
42.
Di MecoA, JoshiYB, PraticòD (2014) Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer’s disease with plaques and tangles. Neurobiol Aging35, 1813–1820.
43.
LiguoriC, RomigiA, NuccetelliM, ZanninoS, SancesarioG, MartoranaA, AlbaneseM, MercuriNB, IzziF, BernardiniS, NittiA, SancesarioGM, SicaF, MarcianiMG, PlacidiF (2014) Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease. JAMA Neurol71, 1498–1505.
44.
MulinE, ZeitzerJM, FriedmanL, Le DuffF, YesavageJ, RobertPH, DavidR (2011) Relationship between apathy and sleep disturbance in mild and moderate Alzheimer’s disease: An actigraphic study. J Alzheimers Dis25, 85–91.
